Received Jan 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | PX3P7 | IM / RA |
Patient received a 2nd dose of Boostrix sooner than recommended. Error was made due to 1st dose not being entered into state registry. Patient did not report any signs or symptoms.
hypertension; hyperthyroidism; hyperlipidemia
Azelastine 137 mcg nasal spray; Atorvastatin 20 mg; Escitalopram 20 mg; Losartan 50 mg; Methimazole 5 mg